Cloudpharm and Cosmos in new gut microbiome-focused pact to address obesity 11-Jul-2022 By Will Chu Greek biopharmaceutical firm Cloudpharm is to team up with Cosmos Holdings in a deal that harnesses the gut microbiome as a basis to develop products addressing obesity.